FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/01/079448 [Registered on: 24/01/2025] Trial Registered Prospectively
Last Modified On: 17/01/2025
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Cosmeceuitcal]  
Study Design  Single Arm Study 
Public Title of Study   Safety and efficacy check of products 
Scientific Title of Study   The objective of this study will be to evaluate the in vivo safety and efficacy of a skin care formulation in terms of reduction in appearance of cellulite on healthy female  
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
XXX-AC01-XC-DR24; Version: 01; Dated: 27/12/2024  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Pooja Yadav 
Designation  Principal Investigator 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra

Mumbai
MAHARASHTRA
400025
India 
Phone  02243349191  
Fax    
Email  poojayadav@mascotspincontrol.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr Pooja Yadav 
Designation  Principal Investigator 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra


MAHARASHTRA
400025
India 
Phone  02243349191  
Fax    
Email  poojayadav@mascotspincontrol.in  
 
Details of Contact Person
Public Query
 
Name  Dr Mohit Lalvani 
Designation  Study Director 
Affiliation  MASCOT-SPINCONTROL India Pvt. Ltd. 
Address  Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra

Mumbai
MAHARASHTRA
400025
India 
Phone  02243349191  
Fax    
Email  mohit.CTRI@gmail.com  
 
Source of Monetary or Material Support  
VLCC Personal care Ltd. Magnum City Centre, Near Birla Navya Township, Sector-63A, Gurugram, Haryana 122011 
 
Primary Sponsor  
Name  VLCC Personal care Ltd. 
Address  Magnum City Centre, Near Birla Navya Township, Sector-63A, Gurugram, Haryana 122011 
Type of Sponsor  Other [Cosmetic/Personal Care Industry] 
 
Details of Secondary Sponsor  
Name  Address 
Nil  NA 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pooja Yadav  Mascot Spincontrol India Pvt. Ltd.   Sea Breeze Building, 9th Floor, Appasaheb Marathe Marg, Century Bazaar, Prabhadevi, Mumbai, Maharashtra
Mumbai
MAHARASHTRA 
02243349191

poojayadav@mascotspincontrol.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Ethos- An Institutional Ethics committee (Mumbai)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  having cellulite on the upper arms, belly & thighs 
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Nil  NA 
Intervention  VL CL PCRGEL  Product to be applied on both Thighs, Both Upper Arms & Belly Area. Application will be twice in a day for the period of 45 days. 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  50.00 Year(s)
Gender  Female 
Details  1)Indian / Asian female subjects
2)Healthy subjects
3)Skin is healthy on the studied anatomic unit
4) Having cellulite on the upper arms, belly and thighs visible with the naked eye  
 
ExclusionCriteria 
Details  1)For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.
2)Having refused to give his/her assent by not signing the consent form
3)Taking part in another study liable to interfere with this study
4)Having a chronic dermatosis liable to modify the cutaneous
reactivity on the tested area
5)Being insulin-dependent diabetic or non insulin-dependent diabetic
with a recent therapy (less than 6 months)
6)Having a progressive asthma (either under treatment or last fit in the last 2 years)
7)Being epileptic
8)Having non stabilized thyroid problems (requirement of a stabilized
treatment for at least 6 months)
9)Having cutaneous hypersensitivity
10)Having a diagnosed or highly probable allergy to one or several
compounds of the cosmetic products
11)Following a chronic or intermittent medicinal treatment comprising
any of the following products: aspirin-based products,
anti-inflammatories, antihistamines, anti-coagulants, corticotherapy,
taken by general or local routes (the only medication permitted is paracetamol)
12)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant Blinded 
Primary Outcome  
Outcome  TimePoints 
Reduction in appearance of cellulite  Baseline, Day 14, Day 28, Day 45 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  NA 
 
Target Sample Size   Total Sample Size="36"
Sample Size from India="36" 
Final Enrollment numbers achieved (Total)= "36"
Final Enrollment numbers achieved (India)="36" 
Phase of Trial   N/A 
Date of First Enrollment (India)   28/01/2025 
Date of Study Completion (India) 17/03/2025 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

OBJECTIVE: The objective of this study will be to evaluate the in vivo safety and efficacy of a skin care formulation in terms of reduction in appearance of cellulite on healthy female subjects

The evaluation is performed using: Subject Self Evaluation, Dermatological Evaluation (Cosmetic Acceptability), Visual Grading of Cellulite

POPULATION: 36 Female subjects are selected for the study.

The subjects selected for this study will be healthy females, aged between 25 and 50 years, having cellulite on the upper arms, belly & thighs visible with the naked eye with a grade higher or equal to 3.

STUDY DURATION: 45 days following the first application of the product.

STUDY DESIGN: Single blind study, Non-comparative study, Subjects do not serve as their own references

 
Close